1-2 of 2
Alexis Magda
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Long Term Results of a Multicenter Prospective Trial By the Lysa Group Evaluating the RiPAD+C Regimen (Combination of Rituximab, Bortezomib, Doxorubicin, Dexamethasone and Chlorambucil) As First-Line Therapy for Elderly Mantle Cell Lymphoma Patients (MCL): Prognostic Value of FDG-PET/CT

Free
Julien Dubreuil, Roch Houot, MD PhD, Steven Le Gouill, Christiane Mounier, MD, Stéphane Courby, MD, Caroline Dartigeas, MD, Krimo Bouabdallah, MD, Marie Pierre Moles, MD, Alexis Magda, Olivier Tournilhac, MD, Mario Ojeda Uribe, Jean Cyril Bourre, Caroline Bodet-Milin, MD, Jean-Philippe Vuillez, MD PhD, Remy Gressin, MD
Journal: Blood
Blood (2014) 124 (21): 3070.
https://doi.org/10.1182/blood.V124.21.3070.3070
Published: 2014
Journal Articles

Gemtuzumab Ozogamicin-Based Salvage, Followed by Allogeneic Hematopoietic Stem Cell Transplantation, Is Highly Effective in Young Patients with Core Binding Factor (CBF) Acute Myeloid Leukemia (AML) in First Relapse

Free
Marie-Anne Hospital, Christian Recher, MD, PhD, Xavier Thomas, Emmanuelle Tavernier, Bruno Lioure, Cécile Pautas, Aurore Perrot, Thorsten Braun, MD, Thomas Cluzeau, Jean-Valère Malfuson, Jerome Tamburini, Céline Berthon, MD, Alexis Magda, Chantal Himberlin, Stephane de Botton, Edouard Randriamalala, Isabelle Plantier, Madalina Uzunov, Philippe Rousselot, Norbert Ifrah, Herve Dombret, Nicolas Boissel
Journal: Blood
Blood (2011) 118 (21): 2603.
https://doi.org/10.1182/blood.V118.21.2603.2603
Published: 2011